DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Velcade (Bortezomib) - Dyspnoea - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Dyspnoea (106)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Velcade (Bortezomib) where reactions include dyspnoea. The selected reports were submitted to the FDA during the sample period of about a year.

 Reports 1 - 30 of 106   Next >>

Possible Velcade side effects in

Reported by a physician from France on 2012-08-23

Patient:

Reactions: Back Pain, Electrocardiogram QT Prolonged, Dyspnoea, Hypotension, Thrombocytopenia

Adverse event resulted in: death, life threatening event, hospitalization

Drug(s) suspected as cause:
Dexamethasone
    Dosage: 20 mg, unk
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2012-05-22
    End date: 2012-05-29

JNJ-26481585
    Dosage: 12 mg, unk
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2012-05-21
    End date: 2012-05-31

Velcade
    Dosage: 2.1 mg, unk
    Indication: Multiple Myeloma
    Start date: 2012-05-22
    End date: 2012-05-29

Other drugs received by patient: Ceftriaxone; Primperan / 00041901 /; Acetaminophen; Zelitrex / 01269701 /; Fentanyl; Atracurium Besylate; Kardegic / 00002703 /; Oxycontin; Oxygen; Tranxene; Primperan / 00041901 /; Bumetanide; Crestor; Primperan / 00041901 /; Hydrocortisone; Ondansetron; Ondansetron; Ondansetron; Importal; Tramadol HCL; Noradrenaline / 00127501 /; Tramadol HCL; Morphine; Furosemide; Midazolam; Tramadol HCL



Possible Velcade side effects in

Reported by a physician from Italy on 2012-08-20

Patient:

Reactions: Dyspnoea, Anaemia, Pancytopenia, Thrombocytopenia, Asthenia

Adverse event resulted in: death, life threatening event, hospitalization

Drug(s) suspected as cause:
Velcade

Other drugs received by patient: Nitroglycerin; Bisoprolol Fumarate; Dexamethasone; Furosemide; Lasix; Dexamethasone



Possible Velcade side effects in female

Reported by a physician from United States on 2012-08-20

Patient: female, weighing 70.8 kg (155.8 pounds)

Reactions: Abdominal Pain, Hyperpyrexia, Anaphylactic Reaction, Chills, Pain, Hepatic Failure, Transaminases Increased, Splenic Infarction, Loss of Consciousness, Aortic Thrombosis, Off Label Use, Malaise, C-Reactive Protein Increased, Myositis, Dyspnoea, Hypotension, Arrhythmia, Lung Consolidation, Hypophosphataemia, Zygomycosis, Bacteraemia, Ventricular Tachycardia, Hyperammonaemia, Neutropenia, Hepatic Infarction, Shock, Infusion Related Reaction

Adverse event resulted in: death, life threatening event

Drug(s) suspected as cause:
Cytarabine
    Dosage: day 1,8, 15 and 22
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2007-10-23

Decadron Phosphate
    Dosage: day 1
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2007-10-23

Doxil
    Dosage: day 1
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2007-10-23
    End date: 2007-10-23

Methotrexate
    Dosage: day 1
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2005-01-01
    End date: 2007-01-01

PEG-Asparaginase
    Dosage: day 2, 8, 15 and 22
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2007-10-25
    End date: 2007-10-25

Velcade
    Dosage: day 1, 4, 8 and 11
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2007-10-23
    End date: 2007-10-23

Vincristine
    Dosage: day 1,8, 15 and 22
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2007-10-23
    End date: 2007-10-23



Possible Velcade side effects in 14 year old male

Reported by a physician from United States on 2012-08-20

Patient: 14 year old male, weighing 71.4 kg (157.1 pounds)

Reactions: Dyspnoea, Hypotension, Sepsis

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Cytarabine
    Dosage: 100 mg/m2, cyclic
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-08-09
    End date: 2012-08-10

Cytarabine
    Dosage: 70 mg, cyclic
    Start date: 2012-08-09
    End date: 2012-08-09

Daunorubicin HCL
    Dosage: 50 mg/m2, cyclic
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-08-09
    End date: 2012-08-09

Etoposide
    Dosage: 100 mg/m2, cyclic
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-08-09
    End date: 2012-08-09

Velcade
    Dosage: 1.3 mg/m2, cyclic
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-08-09
    End date: 2012-08-09



Possible Velcade side effects in

Reported by a physician from Germany on 2012-08-17

Patient:

Reactions: Dyspnoea, Tachycardia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Velcade

Other drugs received by patient: Acyclovir; Dexamethasone; Pamidronate Disodium



Possible Velcade side effects in

Reported by a physician from France on 2012-08-16

Patient:

Reactions: Electrocardiogram QT Prolonged, Back Pain, Dyspnoea, Hypotension, Thrombocytopenia

Adverse event resulted in: death, life threatening event, hospitalization

Drug(s) suspected as cause:
Dexamethasone
    Dosage: 20 mg, unk
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2012-05-22
    End date: 2012-05-29

JNJ-26481585
    Dosage: 12 mg, unk
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2012-05-21
    End date: 2012-05-31

Velcade
    Dosage: 2.1 mg, unk
    Indication: Multiple Myeloma
    Start date: 2012-05-22
    End date: 2012-05-29

Other drugs received by patient: Ceftriaxone; Primperan / 00041901 /; Bumetanide; Acetaminophen; Morphine; Atracurium Besylate; Ondansetron; Crestor; Fentanyl; Furosemide; Midazolam; Tranxene; Ondansetron; Tramadol HCL; Noradrenaline / 00127501 /; Hydrocortisone; Importal; Tramadol HCL; Kardegic / 00002703 /; Primperan / 00041901 /; Primperan / 00041901 /; Tramadol HCL; Zelitrex / 01269701 /; Oxycontin; Oxygen; Ondansetron



Possible Velcade side effects in

Reported by a physician from NEW Zealand on 2012-08-14

Patient:

Reactions: Dyspnoea, Diaphragmatic Paralysis

Drug(s) suspected as cause:
Velcade

Other drugs received by patient: Thalidomide; Dexamethasone



Possible Velcade side effects in female

Reported by a physician from United States on 2012-08-14

Patient: female, weighing 70.8 kg (155.8 pounds)

Reactions: Abdominal Pain, Rhabdomyolysis, Hyperpyrexia, Chills, Anaphylactic Reaction, Bone Pain, Hepatic Failure, Transaminases Increased, Loss of Consciousness, Aortic Thrombosis, Splenic Infarction, Hypokalaemia, Malaise, C-Reactive Protein Increased, Dyspnoea, Hypotension, Hypophosphataemia, Zygomycosis, Bacteraemia, Hyperammonaemia, Neutropenia, Hepatic Infarction, Lung Infiltration, Shock, Infusion Related Reaction

Adverse event resulted in: death, life threatening event, hospitalization

Drug(s) suspected as cause:
Cytarabine
    Dosage: 70 mg, unk
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2005-01-01
    End date: 2007-10-23

Decadron Phosphate
    Dosage: 9 mg, unk
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2007-10-23
    End date: 2007-10-23

Doxorubicin HCL
    Dosage: 107 mg, unk
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2007-10-23
    End date: 2007-10-23

Methotrexate Sodium
    Dosage: unk, unk
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2005-01-01
    End date: 2007-01-01

Pegaspargase
    Dosage: unk, unk
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2007-10-25

Velcade
    Dosage: 1.3 mg/m2, unk
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2007-10-23
    End date: 2007-10-23

Vincristine
    Dosage: 2 mg, unk
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2007-10-23
    End date: 2007-10-23



Possible Velcade side effects in female

Reported by a physician from United States on 2012-08-10

Patient: female, weighing 62.0 kg (136.4 pounds)

Reactions: Blood Alkaline Phosphatase Increased, Pneumonia Fungal, Dyspnoea, Hypotension, Muscular Weakness, Febrile Neutropenia, Hypokalaemia, Dehydration, Hypoxia, Pulmonary Oedema, Hypoalbuminaemia, Neutrophil Count Decreased, Renal Failure Acute

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Decitabine
    Dosage: 20 mg/m2, cyclic
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-02-27
    End date: 2012-05-06

Velcade
    Dosage: 1.3 mg/m2, cyclic
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-02-27
    End date: 2012-05-06



Possible Velcade side effects in

Reported by a physician from Germany on 2012-08-09

Patient:

Reactions: Dyspnoea, C-Reactive Protein Increased, General Physical Health Deterioration

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Dexamethasone
    Dosage: unk
    Indication: Multiple Myeloma
    Start date: 2011-01-26
    End date: 2012-07-18

Velcade
    Dosage: unk
    Indication: Multiple Myeloma
    Start date: 2011-01-26
    End date: 2012-07-18



Possible Velcade side effects in male

Reported by a physician from United States on 2012-08-09

Patient: male, weighing 31.8 kg (70.0 pounds)

Reactions: Abdominal Pain, Atelectasis, Disseminated Intravascular Coagulation, Acidosis, Pericardial Effusion, Activated Partial Thromboplastin Time Prolonged, Multi-Organ Failure, Left Ventricular Dysfunction, Pulmonary Oedema, Mediastinal Haemorrhage, Blood Creatinine Increased, Renal Failure Acute, Dyspnoea, Angina Pectoris, Alanine Aminotransferase Increased, Hypotension, Hypercalcaemia, Respiratory Failure, Embolism, Cardiac Failure, Aspartate Aminotransferase Increased, Ventricular Tachycardia, Ejection Fraction Decreased, Hypoalbuminaemia, Ventricular Fibrillation, Sinus Tachycardia

Adverse event resulted in: death, life threatening event, hospitalization

Drug(s) suspected as cause:
Ativan
    Indication: Product Used FOR Unknown Indication

Cytarabine
    Dosage: 100 mg/kg, unk
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-06-01
    End date: 2012-06-11

Daunorubicin HCL
    Dosage: 50 mg/m2, cyclic
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-06-01
    End date: 2012-06-05

Etoposide
    Dosage: 100 mg/m2, cyclic
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-06-01
    End date: 2012-06-05

Fentanyl
    Indication: Product Used FOR Unknown Indication

Velcade
    Dosage: 1.3 mg/m2, cyclic
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-06-01
    End date: 2012-06-01



Possible Velcade side effects in male

Reported by a physician from Italy on 2012-08-08

Patient: male

Reactions: Blood Bilirubin Increased, Liver Injury, Blood Alkaline Phosphatase Increased, Dyspnoea, Alanine Aminotransferase Increased, Malaise, Gamma-Glutamyltransferase Increased, C-Reactive Protein Increased, Aspartate Aminotransferase Increased, Cytomegalovirus Infection, Blood Creatinine Increased, Hepatitis B, Gravitational Oedema

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Alkeran
    Dosage: 16mg per day
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2012-02-14
    End date: 2012-02-17

Velcade
    Dosage: 2.6mg per day
    Indication: Multiple Myeloma
    Start date: 2012-02-21
    End date: 2012-02-28

Other drugs received by patient: Prednisone TAB; Acyclovir



Possible Velcade side effects in female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-02

Patient: female

Reactions: Abdominal Rigidity, Dyspnoea, Hepatic Failure, Hypoaesthesia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Velcade
    Dosage: 1.3 mg/m2, unk
    Indication: Product Used FOR Unknown Indication

Velcade
    Dosage: 1.0 mg/m2, unk



Possible Velcade side effects in 66 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-30

Patient: 66 year old female, weighing 90.8 kg (199.8 pounds)

Reactions: Pulmonary Hypertension, Gastrointestinal Haemorrhage, Acute Myocardial Infarction, Clostridial Infection, Immunosuppression, Renal Failure Acute, Cardiac Failure Congestive, Pneumonia, Dyspnoea, Malnutrition, Febrile Neutropenia, Encephalopathy, Atrial Fibrillation, Urinary Tract Infection Enterococcal, Renal Failure, Respiratory Failure, Renal Tubular Necrosis, Asthenia, Hypogammaglobulinaemia

Adverse event resulted in: death, life threatening event, hospitalization, disablity

Drug(s) suspected as cause:
Dexamethasone
    Dosage: 2.8571 milligram
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2010-12-18
    End date: 2011-06-02

Dexamethasone
    End date: 2012-04-10

Prednisone
    Indication: Multiple Myeloma

Revlimid
    Dosage: 25 milligram
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2010-12-20
    End date: 2011-06-09

Revlimid
    Administration route: Oral
    End date: 2012-05-01

Velcade
    Dosage: .2714 milligram
    Indication: Multiple Myeloma
    Start date: 2010-12-12
    End date: 2011-06-02

Velcade
    End date: 2012-04-10

Other drugs received by patient: Lotrel; Pravastatin; Vitamin D; Coreg; Doxepin; Tricore; Betaseron; Acyclovir; Allopurinol; Aspirin; Heocyte; Metformin Hydrochloride; Warfarin Sodium; Doxil



Possible Velcade side effects in 78 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-26

Patient: 78 year old female, weighing 46.7 kg (102.7 pounds)

Reactions: Dyspnoea, Chest Pain

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Dexamethasone
    Dosage: 32 mg, unk
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2012-03-23

Velcade
    Dosage: 1.5 mg, unk
    Indication: Multiple Myeloma
    Start date: 2012-03-19

Other drugs received by patient: Methadone Hydrochloride; Fluconazole; Metoclopramide; Vantin / 01043502 /; Losartan Potassium; Senna / 00142201 /; Valtrex; Norvasc; Miralax; Prilosec; Dilaudid; Magnesium Oxide



Possible Velcade side effects in male

Reported by a physician from United States on 2012-07-24

Patient: male, weighing 31.8 kg (70.0 pounds)

Reactions: Atelectasis, Abdominal Pain, Disseminated Intravascular Coagulation, Acidosis, Pericardial Effusion, Multi-Organ Failure, Activated Partial Thromboplastin Time Prolonged, Left Ventricular Dysfunction, Pulmonary Oedema, Mediastinal Haemorrhage, Blood Creatinine Increased, Renal Failure Acute, Dyspnoea, Angina Pectoris, Hypotension, Alanine Aminotransferase Increased, Hypercalcaemia, Embolism, Cardiac Failure, Respiratory Failure, Ventricular Tachycardia, Ejection Fraction Decreased, Aspartate Aminotransferase Increased, Hypoalbuminaemia, Ventricular Fibrillation, Sinus Tachycardia

Adverse event resulted in: death, life threatening event, hospitalization

Drug(s) suspected as cause:
Ativan
    Dosage: unk
    Indication: Product Used FOR Unknown Indication

Cytarabine
    Dosage: unk
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-06-01
    End date: 2012-06-11

Cytarabine
    Dosage: 100 mg/kg, bid
    Start date: 2012-06-01
    End date: 2012-06-03

Daunorubicin Hydrochloride
    Dosage: 50 mg/m2, cyclic
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-06-01
    End date: 2012-06-05

Etoposide
    Dosage: 100 mg/m2, cyclic
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-06-01
    End date: 2012-06-05

Fentanyl
    Indication: Product Used FOR Unknown Indication

Velcade
    Dosage: 1.3 mg/m2, cyclic
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-06-01
    End date: 2012-06-01



Possible Velcade side effects in

Reported by a physician from Italy on 2012-07-19

Patient:

Reactions: Dyspnoea, Injury, Fall

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Velcade



Possible Velcade side effects in 66 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-18

Patient: 66 year old female, weighing 90.8 kg (199.8 pounds)

Reactions: Pulmonary Hypertension, Gastrointestinal Haemorrhage, Death, Acute Myocardial Infarction, Clostridial Infection, Cardiac Failure Congestive, Immunosuppression, Renal Failure Acute, Pneumonia, Dyspnoea, Malnutrition, Atrial Fibrillation, Febrile Neutropenia, Encephalopathy, Urinary Tract Infection Enterococcal, Renal Failure, Respiratory Failure, Renal Tubular Necrosis, Asthenia, Hypogammaglobulinaemia

Adverse event resulted in: death, life threatening event, hospitalization, disablity

Drug(s) suspected as cause:
Dexamethasone
    Dosage: 2.8571 milligram
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2010-12-18
    End date: 2011-06-02

Dexamethasone
    End date: 2012-04-10

Prednisone
    Indication: Multiple Myeloma

Revlimid
    Dosage: 25 milligram
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2010-12-20
    End date: 2011-06-09

Revlimid
    Administration route: Oral
    End date: 2012-05-01

Velcade
    End date: 2012-04-10

Velcade
    Dosage: .2714 milligram
    Indication: Multiple Myeloma
    Start date: 2010-12-12
    End date: 2011-06-02

Other drugs received by patient: Doxil; Coreg; Pravastatin; Heocyte; Betaseron; Lotrel; Aspirin; Vitamin D; Warfarin Sodium; Allopurinol; Doxepin; Acyclovir; Metformin Hydrochloride; Tricore



Possible Velcade side effects in male

Reported by a consumer/non-health professional from United States on 2012-07-17

Patient: male, weighing 31.8 kg (70.0 pounds)

Reactions: Abdominal Pain, Acidosis, Pericardial Effusion, Left Ventricular Dysfunction, Hypocalcaemia, Renal Failure Acute, Pneumonitis, Dyspnoea, Angina Pectoris, Hypotension, Anaemia, Delirium, Tumour Lysis Syndrome, Respiratory Failure, Cardiac Failure, Aspartate Aminotransferase Increased, Ejection Fraction Decreased, Sinus Tachycardia, Hypertension

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Ativan
    Dosage: unk
    Indication: Product Used FOR Unknown Indication

Cytarabine
    Dosage: 100 mg/kg, bid
    Start date: 2012-06-01
    End date: 2012-06-03

Cytarabine
    Dosage: unk
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-06-01
    End date: 2012-06-11

Daunorubicin Hydrochloride
    Dosage: 50 mg/m2, cyclic
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-06-01
    End date: 2012-06-05

Etoposide
    Dosage: 100 mg/m2, cyclic
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-06-01
    End date: 2012-06-05

Fentanyl
    Indication: Product Used FOR Unknown Indication

Velcade
    Dosage: 1.3 mg/m2, cyclic
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-06-01
    End date: 2012-06-01



Possible Velcade side effects in

Reported by a consumer/non-health professional from United States on 2012-07-16

Patient:

Reactions: Vomiting, Dyspnoea, Nausea, Pyrexia, Cardiomyopathy, Renal Failure Chronic, Weight Increased, Tumour Lysis Syndrome, Fatigue, Respiratory Failure, Vitamin B12 Deficiency, Alopecia, Ejection Fraction Decreased, Arteriosclerosis Coronary Artery, Respiratory Tract Infection, Cardiac Failure Congestive

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Dexamethasone
    Dosage: 20 mg, cyclic
    Indication: Multiple Myeloma

Velcade
    Dosage: 1.3 mg/m2, cyclic
    Indication: Multiple Myeloma
    Start date: 2007-11-05
    End date: 2007-12-03

Other drugs received by patient: OS-CAL / 00108001 /; Colace; Nexium; Synthroid; Allopurinol; Lasix; Lisinopril; Lovenox; Aspirin



Possible Velcade side effects in 66 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-13

Patient: 66 year old female, weighing 90.8 kg (199.8 pounds)

Reactions: Pulmonary Hypertension, Gastrointestinal Haemorrhage, Death, Acute Myocardial Infarction, Clostridial Infection, Renal Failure Acute, Immunosuppression, Cardiac Failure Congestive, Pneumonia, Dyspnoea, Malnutrition, Febrile Neutropenia, Atrial Fibrillation, Encephalopathy, Urinary Tract Infection Enterococcal, Renal Failure, Respiratory Failure, Renal Tubular Necrosis, Asthenia, Hypogammaglobulinaemia

Adverse event resulted in: death, life threatening event, hospitalization, disablity

Drug(s) suspected as cause:
Dexamethasone
    Dosage: 2.8571 milligram
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2010-12-18
    End date: 2011-06-02

Dexamethasone
    End date: 2012-04-10

Prednisone
    Indication: Multiple Myeloma

Revlimid
    Dosage: 25 milligram
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2010-12-20
    End date: 2011-06-09

Revlimid
    Administration route: Oral
    End date: 2012-05-01

Velcade
    End date: 2012-04-10

Velcade
    Dosage: .2714 milligram
    Indication: Multiple Myeloma
    Start date: 2010-12-12
    End date: 2011-06-02

Other drugs received by patient: Betaseron; Lotrel; Coreg; Doxepin; Vitamin D; Warfarin Sodium; Pravastatin; Doxil; Acyclovir; Allopurinol; Heocyte; Tricore; Aspirin; Metformin Hydrochloride



Possible Velcade side effects in

Reported by a physician from Finland on 2012-07-13

Patient:

Reactions: Off Label Use, Dyspnoea, Coronary Artery Disease

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Velcade

Other drugs received by patient: Dexamethasone; Epoetin Zeta



Possible Velcade side effects in

Reported by a physician from United Kingdom on 2012-07-10

Patient:

Reactions: Off Label Use, Dyspnoea, Hypotension, Chest Pain, Pleural Effusion, Troponin Increased, Pyrexia, Myocardial Infarction

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Velcade

Other drugs received by patient: Bendroflumethiazide; Codeine Sulfate; Dexamethasone; Gabapentin; Ibuprofen; Bisacodyl; Acetaminophen; Pamidronate Disodium; Amitriptyline HCL; Diazepam; Enoxaparin; Tramadol HCL



Possible Velcade side effects in

Reported by a consumer/non-health professional from United States on 2012-07-09

Patient:

Reactions: Dyspnoea, Anaemia, General Physical Health Deterioration, Oesophageal Haemorrhage, Thrombocytopenia, Infection

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Dexamethasone
    Dosage: 8 mg, cyclic
    Indication: Multiple Myeloma
    Start date: 2010-08-30
    End date: 2011-11-04

Doxorubicin HCL
    Dosage: 9 mg/m2, cyclic
    Indication: Multiple Myeloma
    Start date: 2011-08-30
    End date: 2011-11-04

Velcade
    Dosage: 1.3 mg, cyclic
    Indication: Multiple Myeloma
    Start date: 2011-08-30
    End date: 2011-11-04

Other drugs received by patient: Moxonidin; Amlodipine; Finasterid Orion; Metoprolol Tartrate; Ramipril; Allopurinol; Levothyroxine Sodium; Calcivit D; Pantozol / 01263202 /; Hydromorphone HCL; Decostriol; Prednisone TAB; Tamsulosin HCL; Torsemide; Folsan



Possible Velcade side effects in female

Reported by a consumer/non-health professional from United States on 2012-07-06

Patient: female

Reactions: Back Pain, Dyspnoea, Pain in Extremity, Bone Pain, Anxiety, Fatigue, Activities of Daily Living Impaired, Coordination Abnormal, Depression, Asthenia

Drug(s) suspected as cause:
Velcade



Possible Velcade side effects in female

Reported by a physician from United States on 2012-07-06

Patient: female, weighing 92.0 kg (202.4 pounds)

Reactions: White Blood Cell Count Decreased, Dyspnoea, Anaemia, Febrile Neutropenia, Muscular Weakness, Acidosis, Renal Failure Chronic, Fatigue, Sepsis, Platelet Count Decreased, Hypoxia, Neutrophil Count Decreased, Lymphocyte Count Decreased, Decreased Appetite

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Decitabine
    Dosage: 20 mg/m2, cyclic
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-05-02
    End date: 2012-06-08

Velcade
    Dosage: 1.3 mg/m2, cyclic
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-05-02
    End date: 2012-06-06



Possible Velcade side effects in

Reported by a consumer/non-health professional from United States on 2012-07-05

Patient:

Reactions: Respiratory Disorder, Dyspnoea

Drug(s) suspected as cause:
Velcade



Possible Velcade side effects in male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-05

Patient: male

Reactions: Cardio-Respiratory Arrest, Dyspnoea

Adverse event resulted in: death

Drug(s) suspected as cause:
Dexamethasone Sodium Phosphate
    Dosage: 20 mg, cyclic
    Indication: Multiple Myeloma

Lenalidomide
    Dosage: 25 mg, cyclic
    Indication: Multiple Myeloma

Velcade
    Dosage: 1.3 mg/m2, cyclic
    Indication: Multiple Myeloma
    Start date: 2010-09-17
    End date: 2010-09-30

Vorinostat
    Dosage: 400 mg, cyclic
    Indication: Multiple Myeloma

Other drugs received by patient: Fish OIL; Aspirin; Fenofibrate; Multi-Vitamins; Colace; Loratadine; Levothyroxine Sodium; Methocarbamol



Possible Velcade side effects in

Reported by a pharmacist from Canada on 2012-06-29

Patient:

Reactions: Dyspnoea, C-Reactive Protein Increased, Lung Infiltration, Oxygen Saturation Decreased

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Velcade

Other drugs received by patient: Vitamin D; Tylenol (Caplet); Cyclophosphamide; Aspirin; Glucosamine; Omega 3 / 01334101 /; Calcium; Centrum / 00554501 /; Synthroid; Lipitor; Dexamethasone; Fish OIL



Possible Velcade side effects in 62 year old female

Reported by a physician from United States on 2012-06-27

Patient: 62 year old female, weighing 62.0 kg (136.4 pounds)

Reactions: Pneumonia Fungal, Blood Alkaline Phosphatase Increased, Dyspnoea, Hypotension, Febrile Neutropenia, Muscular Weakness, Hypokalaemia, Dehydration, Hypoxia, Hypoalbuminaemia, Pulmonary Oedema, Neutrophil Count Decreased, Renal Failure Acute

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Decitabine
    Dosage: 20 mg/m2, cyclic
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-02-27
    End date: 2012-05-06

Velcade
    Dosage: 1.3 mg/m2, cyclic
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-02-27
    End date: 2012-05-06



 Page 1   Next >>

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017